Acrylamide has been discovered in foods cooked at high temperature. A potentially harmful effect of this dietary component has been suggested by data indicating its association with increased breast cancer. This study investigated the potential effects of acrylamide in nontumorigenic breast cells by assessing expression levels of inducible nitric oxide synthase (iNOS) and cycloogenase-2 (Cox-2) and NOS activity, which are known to be early molecular changes in disease formation. Treatment of cells with acrylamide increased levels of iNOS (both expression and activity) and Cox-2. Its potent metabolite, glycidamide, also induced both iNOS and Cox-2, with induction of iNOS occurring at a lower concentration. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), another food-borne carcinogen, was found to induce Cox-2 expression. Combining acrylamide with PhIP did not result in a further increase. These studies suggest that further research is needed to determine the role of carcinogens formed from cooking foods in inducing early molecular changes associated with breast cancer.
Baum M., Fauth E., Fritzen S., Hermann A., Mertes P., Rudolphi M., et al. (2005) Acrylamide and glycidamide: genotoxic effects in V79-cells and human blood. Mutation Research580(1-2): 61-69.
2.
Bing RJ ( 2001) Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast. Clinical Cancer Research7(11): 3385-3392.
3.
Bjellaas T., Olesen PT, Frandsen H., Haugen M., Stolen LH, Paulsen JE, et al. (2007) Comparison of estimated dietary intake of acrylamide with haemoglobin adducts of acrylamide and glycidamide. Toxicological Sciences98(1): 110-117.
4.
Boland GP, Butt IS, Prasad R., Knox WF, and Bundred NJ ( 2004) Cox-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. British Journal of Cancer90(2): 423-429.
5.
Boettcher MI, Bolt HM, Drexler H., and Angerer J. ( 2006) Excretion of mercapturic acids of acrylamide and glycidamide in human uring after single oral administration of deuterium-labelled acrylamide . Archives of Toxicology80(2): 55-61.
6.
Carere A. ( 2006) Genotoxicity and carcinogenicity of acrylamide: a critical review. Annali Dell’Istituto Superiore Di Sanità42(2): 144-155.
7.
Chen T., Stoner GD ( 2004) Inducible nitric oxide synthase expression in N-nitrosomethylbenzylamine (NMBA)-induced rat esophageal tumorigenesis. Molecular Carcinogenesis40(4): 232-240.
8.
Clement FC, Dip R., and Naegeli H. ( 2007) Expression profile of human cells in culture exposed to glycidamide, a reactive metabolite of the heat-induced food carcinogen acrylamide . Toxicology240(1-2): 111-124.
9.
Creton S., Zhu H., and Gooderham NJ ( 2005) A mechanistic basis for the role of cycle arrest in the genetic toxicology of the dietary carcinogen 2-amino-1methyl-6-phenylimidazon[4,5]pyridine (PhIP). Toxicological Sciences84: 335-343.
10.
Dybing E., Farmer PB, Andersen M., Fennell TR, Lalljie SP, Muller DJ, et al.(2005) Human exposure and internal dose assessments of arcylamide in food. Food and Chemical Toxicology43(3): 365-410.
11.
Dybing E., Sanner T. ( 2003) Risk assessment of acrylamide in foods. Toxicological Sciences75(1): 7-15.
12.
Erdriech LS, Friedman MA ( 2004) Epidemiologic evidence for assessing the carcinogenicity of acrylamide. Regulatory Toxicology and Pharmacology39(2): 150-157.
13.
Fennell TR, Sumner SC, Snyder RW, Burgess J., Spicer R., Bridson WE, et al. (2005) Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicological Sciences85(1): 447-459.
14.
Friedman MA ( 2003) Chemistry, biochemistry, and safety of acrylamide. A review . Journal of Agriculture and Food Chemistry51(16): 4504-4526.
15.
Friedman MA, Dulak LH, and Stedham MA ( 1995) A lifetime oncogenicity study in rats with acrylamide . Fundamental and Applied Toxicology27(1): 95-105.
16.
Golde S., Chandran S., Brown GC, and Compston A. ( 2002) Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression. Journal of Neurochemistry82(2): 269-282.
17.
Hashimoto K., Torii H. ( 1985) Mutagenicity of acrylamide and its analogues in Salmonella typhimurium. Mutation Research158(3): 129-133.
18.
Heales SJ, Bolanos JP, Stewart VC, Brookes PS, Land JM, and Clark JB ( 1999) Nitric oxide, mitochondria and neurological disease. Biochimica et Biophysica Acta1410(2): 215-228.
19.
Hofseth LJ ( 2008) Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer. Cancer Letters268(1): 10-30.
20.
Horton JK, Williams AS, Smith-Phillips Z., Martin RC, and O’Beirne G. (1999) Intracellular measurement of prostaglandin E2; effects of anti-inflammatory drugs on cyclooxygenase activity and prostanoid expression. Analytical Biochemistry271(1): 18-28.
21.
Howe LR, Dannenberg AJ ( 2003) Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Journal of Mammary Gland8(2): 31-32.
22.
Jaiswal M., LaRusso NF, and Gores GJ ( 2001) Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. American Journal of Physiology Gastrointestinal and Liver Physiology281(3): G626-G634.
23.
Kang YJ, Mbonye UR, DeLong CJ, Wada M., and Smith WL ( 2007) Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Progress in Lipid Research46(2): 108-125.
24.
Kundu JK, Surh YJ ( 2008) Inflammation: gearing the journey to cancer. Mutation Research659(1-2): 15-30.
25.
Loibl S., Buck A., Strank C., von Minckwitz G., Roller M., Sinn HP, et al. (2005) The role of early expression of inducible nitric oxide synthase in human breast cancer. European Journal of Cancer41(2): 265-271.
26.
Lynch AM, Knize MG, Boobis AR, Gooderham NJ, Davies DS, and Murrary S. ( 1992) Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5]quinoxaline and 2-amino-1-methyl-6-phenyl-imidazo [4,5]pyridine, carcinogens present in cooked beef. Cancer Research52(22): 6216- 6223.
27.
Manjanatha MG, Aidoo A., Shelton SD, Bishop ME, McDaniel LP, Lyn-Cook LE, et al. (2006) Genotoxicity of acrylamide and its metabolite glycidamide administrated in drinking water to male and female big blue mice . Environmental and Molecular Mutagenesis47(1): 6-17.
28.
Mottram DS, Wedzicha BL, and Dodson AT ( 2002) Acrylamide is formed in the Maillard reaction. Nature419(6906): 448-449.
29.
Mucci LA, Sandin S., Balter K., Adami HO, Magnusson C., and Weiderpass E. ( 2005) Acrylamide intake and breast cancer risk in Swedish women . Journal of the American Medical Association293(11): 1326-1327.
30.
Nie D. ( 2007) Cyclooxygenases and lipoxygenases in prostate and breast cancers. Frontiers in Biosciences12: 1574-1585.
31.
Olesen PT, Olsen A., Frandsen H., Frederiksen K., Overvad K., and Tjonneland A. ( 2008) Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health study. International Journal of Cancer122(9): 2094-2100.
32.
Park J., Kamedjulis LM, Friedman MA, and Klaunig JE ( 2002) Acrylamide-induced cellular transformation. Toxicological Sciences65(2): 177-183.
33.
Paulsson B., Kotova N., Grawe J., Henderson A., Granath F., Golding B., et al. (2003) Induction of micronuclei in mouse and rat by glycidamide, genotoxic metabolite of acrylamide. Mutation Research535(1): 15-24.
34.
Pelucchi C., Galeone C., Levi F., Negri E., Fanceschi S., Talamini R., et al. (2006) Dietary acrylamide and human cancer. International Journal of Cancer118(2): 467-471.
35.
Reis-Filho JS, Tutt AN ( 2008) Triple negative tumours: a critical review. Histopathology52(1): 108-118.
36.
Rice JM ( 2005) The carcinogenicity of acrylamide. Mutation Research580(1-2): 3-20.
37.
Saha RN, Pahan K. ( 2006) Regulation of inducible nitric oxide synthase gene in glial cells. Antioxidants and Redox Signaling8(5-6): 929-947.
38.
Settels E., Bernauer U., Palavinskas R., Klaffke JS, Gundert-Remy U., and Appel KE ( 2008) Human CYP2E1 mediates the formation of glycidamide from acrylamide. Archives of Toxicology82(10): 717-727.
39.
Sickles DW, Stone JD, and Friedman MA ( 2002) Fast axonal transport: a site of acrylamide neurotoxicity ? Neurotoxicology23(2): 223-251.
40.
Singh-Ranger G., Salhab M., and Mokbel K. ( 2008) The role of cyclooxygenase-2 in breast cancer: review . Breast Cancer Research and Treatment109(2): 189-198.
41.
Smigal C., Jemal A., Ward E., Cokkinides V., Smith R., Howe HL, et al. (2006) Trends in breast cancer by race and ethnicity: update 2006. CA: A Cancer Journal for Clinicians56(3): 168-183.
42.
Spencer PS, Schaumburg HH ( 1974) A review of arcylamide neurotoxicity. Part I. Properties, uses, and human exposure. Canadian Journal of Neurological Sciences1: 143-150.
43.
Tareke E., Lyn-Cook BD, Duhart H., Newport G., and Syed A. ( 2009) Acrylamide decreased dopamine levels and increased 3-nitrotyrosine (3-NT) levels in PC 12 cells. Neuroscience Letters458(2): 89-92.
44.
Tareke E., Rydberg P., Karlsson P., Eriksson S., and Tornqvist M. ( 2002) Analysis of acrylamide. A carcinogen formed in heated foodstuffs. Journal of Agriculture and Food Chemistry50(17): 4998-5006.
45.
Willett WC ( 1990) Epidemiological studies of diet and cancer. Progress in Clinical Biological Chemistry346:159-168.
46.
Yun CH, Son CG, Jung U., and Han SH ( 2006) Immunosuppressive effect of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through the inhibition of T-lymphocyte proliferation and IL-2 production . Toxicology217(1): 31-38.
47.
Zyzak DV, Sanders RA, Stojanavic M., Tallmadge DH, Eberhart BL, Ewald DK, et al. (2003) Acrylamide formation mechanism in heated foods. Journal of Agriculture and Food Chemistry51(16): 4782-4787.
